Demonstration of Functional Similarity Comparing Adalimumab to Biosimilar Candidate ABP 501.

被引：0
|
作者：
Born, Teresa [1 ]
Velayudhan, Jyoti [1 ]
Chen, Yuhfung [2 ]
Thomas, Heather [1 ]
Pastula, Christina [1 ]
Maher, Gwen [2 ]
Brown, Ryan [1 ]
机构：
[1] Amgen Inc, Seattle, WA USA
[2] Amgen Inc, Thousand Oaks, CA USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2014年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1503
引用
收藏
页码：S661 / S661
页数：1
相关论文
共 50 条
  • [11] Analytical and Functional Similarity of the Biosimilar Candidate ABP 654 to Ustekinumab Reference Product
    Cantin, Greg
    Liu, Qian
    Shah, Bhavana
    Kuhns, Scott
    Wikstrom, Mats
    Cao, Shawn
    Liu, Jennifer
    DRUGS IN R&D, 2023, 23 (04) : 421 - 438
  • [12] Analytical and Functional Similarity of the Biosimilar Candidate ABP 654 to Ustekinumab Reference Product
    Greg Cantin
    Qian Liu
    Bhavana Shah
    Scott Kuhns
    Mats Wikström
    Shawn Cao
    Jennifer Liu
    Drugs in R&D, 2023, 23 : 421 - 438
  • [13] Demonstration of functional similarity of a biosimilar adalimumab SB5 to Humira®
    Lee, JongAh Joanne
    Yang, Junmo
    Lee, Changsoo
    Moon, Youngjin
    Ahn, Sehee
    Yang, Jiyoon
    BIOLOGICALS, 2019, 58 : 7 - 15
  • [14] SPOSAB ABP 501: A Sicilian Prospective Observational Study of Patients with Inflammatory Bowel Disease Treated with Adalimumab Biosimilar ABP 501
    Macaluso, Fabio Salvatore
    Cappello, Maria
    Busacca, Anita
    Fries, Walter
    Viola, Anna
    Costantino, Giuseppe
    Magnano, Antonio
    Vinci, Elisa
    Ferracane, Concetta
    Privitera, Antonino Carlo
    Piccillo, Giovita
    Belluardo, Nunzio
    Giangreco, Emiliano
    Romano, Claudio
    Citrano, Michele
    Graziano, Francesco
    Garufi, Serena
    Bertolami, Carmelo
    Ventimiglia, Marco
    Scrivo, Barbara
    Teresi, Giulia
    Renna, Sara
    Rizzuto, Giulia
    Casa, Angelo
    Orlando, Ambrogio
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 (11) : 3041 - 3049
  • [15] A Review of the Totality of Evidence Supporting the Development of the First Adalimumab Biosimilar ABP 501
    Richard Markus
    Helen J. McBride
    Monica Ramchandani
    Vincent Chow
    Jennifer Liu
    Dan Mytych
    Gary Fanjiang
    Advances in Therapy, 2019, 36 : 1833 - 1850
  • [16] Effectiveness and safety of switching to adalimumab biosimilar ABP 501 in Crohn's disease
    Viscido, Angelo
    Latella, Giovanni
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2021, 113 (02) : 154 - 155
  • [17] USE OF ADALIMUMAB BIOSIMILAR ABP 501 IN CROHN'S DISEASE: AN OBSERVATIONAL STUDY
    Ribaldone, D. G.
    Vernero, M.
    Pellicano, R.
    Morino, M.
    Saracco, G. M.
    Astegiano, M.
    DIGESTIVE AND LIVER DISEASE, 2020, 52 : S118 - S118
  • [18] A Review of the Totality of Evidence Supporting the Development of the First Adalimumab Biosimilar ABP 501
    Markus, Richard
    McBride, Helen J.
    Ramchandani, Monica
    Chow, Vincent
    Liu, Jennifer
    Mytych, Dan
    Fanjiang, Gary
    ADVANCES IN THERAPY, 2019, 36 (08) : 1833 - 1850
  • [19] SPOSAB ABP 501: A SICILIAN PROSPECTIVE OBSERVATIONAL STUDY OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH ADALIMUMAB BIOSIMILAR ABP 501
    Macaluso, F. S.
    Cappello, M.
    Busacca, A.
    Fries, W.
    Viola, A.
    Costantino, G.
    Magnano, A.
    Vinci, E.
    Ferracane, C.
    Privitera, A. C.
    Piccillo, G.
    Belluardo, N.
    Giangreco, E.
    Romano, C.
    Citrano, M.
    Graziano, F.
    Garufi, S.
    Bertolami, C.
    Ventimiglia, M.
    Scrivo, B.
    Renna, S.
    Rizzuto, G.
    Casa, A.
    Orlando, A.
    DIGESTIVE AND LIVER DISEASE, 2021, 53 : S162 - S163
  • [20] ADALIMUMAB THERAPEUTIC DRUG MONITORING TEST VALIDATED FOR MEASURING ABP 501 BIOSIMILAR
    Begona Ruiz-Arguello, M.
    Maguregui, Ainara
    Martinez, Antonio
    Nagore, Daniel
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1663 - 1663
12345